Puylaert Kevin's Form 4 filing
SOPHiA GENETICS SA (SOPH) · filed Jul 7, 2026
- Accession no.
- 0001840706-26-000248
- Filed
- Jul 7, 2026, 4:03 PM ET
- Trade date
- Jul 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.09K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Puylaert KevinCIK 0002119354 | Officer (Chief Sales Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Ordinary Shares | SSaleDisposed | −138 | $5.03 | −$693.46 | 148,026 | Direct | |
| Jul 6, 2026 | Ordinary Shares | SSaleDisposed | −47 | $5.03 | −$236.18 | 147,979 | Direct | |
| Jul 6, 2026 | Ordinary Shares | SSaleDisposed | −31 | $5.09 | −$157.67 | 147,948 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.